Abstract
Osteoarthritis (OA) is the most prevalent musculoskeletal disorder worldwide and a leading cause of chronic pain, disability, and reduced quality of life. Traditionally conceptualized as a degenerative condition driven by mechanical wear and age-related structural deterioration of articular cartilage, this paradigm does not adequately explain the heterogeneity of clinical presentation, the weak correlation between structural damage and pain, or the limited efficacy of many current therapeutic strategies. Growing evidence supports a conceptual shift in which osteoarthritis is understood as a biologically active disorder of impaired adaptation. Within this framework, OA reflects the reduced capacity of joint tissues to maintain homeostasis in response to cumulative mechanical, metabolic, and inflammatory stressors. Rather than representing an inevitable consequence of aging or mechanical overload alone, osteoarthritis can be interpreted as a failure of coordinated adaptive responses across the whole joint organ. This narrative review aims to synthesize current evidence from inflammation biology, mechanotransduction, and epigenetic regulation to develop an integrative model of osteoarthritis as diminished adaptive capacity. Physical activity is examined as a biologically active intervention capable of modulating inflammatory tone, restoring mechanosensitivity, and supporting functional resilience. This review is based on a structured, non-systematic literature search conducted in PubMed and Scopus, focusing on publications addressing osteoarthritis, inflammation, mechanobiology, epigenetic regulation, and physical activity. Emphasis was placed on high-quality reviews, mechanistic experimental studies, and clinically relevant translational research published predominantly within the past 15 years, alongside seminal foundational work.
References
1. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64(6):1697–1707.
2. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745–1759.
3. Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci. 2010;1192:230–237.
4. Sellam J, Berenbaum F. The role of synovitis in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2010;6:625–635.
5. Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576–590.
6. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505–522.
7. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013;21(1):16–21.
8. Robinson WH, Lepus CM, Wang Q, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12:580–592.
9. Guilak F, Nims RJ, Dicks A, et al. Mechanobiology of cartilage and osteoarthritis. Nat Rev Rheumatol. 2018;14:465–479.
10. Vincent TL. Mechanoflammation in osteoarthritis pathogenesis. Semin Arthritis Rheum. 2019;49(3S):S36–S38.
11. Roach HI, Aigner T. DNA methylation in osteoarthritis. Ann Rheum Dis. 2007;66:552–557.
12. Zhang Y, Fukui N, Yahata M, et al. Epigenetic regulation in osteoarthritis. Arthritis Rheumatol. 2020;72(4):556–569.
13. Fransen M, McConnell S, Harmer AR, et al. Exercise for osteoarthritis of the knee. Cochrane Database Syst Rev. 2015.
14. Bennell KL, Hinman RS. Exercise as a treatment for osteoarthritis. Curr Opin Rheumatol. 2015;27(3):304–311.
15. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457–465.
16. Hunter DJ, Bierma-Zeinstra S. Managing osteoarthritis. BMJ. 2019;366:l5001.
17. Conaghan PG, Kloppenburg M, Schett G, Bijlsma JW. Osteoarthritis research priorities: a report from a EULAR ad hoc expert committee. Ann Rheum Dis. 2014;73:1442–1445.
18. Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis. JAMA. 2021;325(6):568–578.
19. Conaghan PG, Kloppenburg M, Schett G, Bijlsma JW. Osteoarthritis research priorities: a report from a EULAR ad hoc expert committee. Ann Rheum Dis. 2014;73:1442–1445.
20. Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis. JAMA. 2021;325(6):568–578.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Irina Momcheva, Vladimir Gonchev, Martin Valkov (Author)
